Form 4: 89bio CFO Exercises Stock Options
Insider Transaction Report
89bio's Chief Financial Officer, Ryan Martins, exercised stock options, increasing his direct beneficial ownership of common stock and correcting a prior administrative error.
Summary
- Ryan Martins, Chief Financial Officer of 89bio, Inc. (ETNB), exercised stock options on October 22, 2025.
- He acquired 76,901 shares of common stock at an exercise price of $3.11 per share.
- He also acquired 3,898 shares of common stock at an exercise price of $4.44 per share.
- Following these transactions, Martins' direct beneficial ownership of 89bio common stock increased to 339,295 shares.
- The filing corrects an administrative error from a previous Form 4 filed on March 27, 2023, which erroneously omitted the exercise of 5,000 options, thereby updating the correct amount of common stock and stock options owned.
- After the exercise, 48,102 stock options remain from a grant of 52,000 shares, which vest quarterly over three years, subject to continued service.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to an insider exercising options and increasing their stake, which can be interpreted as a sign of confidence. The correction of a past administrative error also contributes to transparency.
Positives
- Increased insider ownership, as the CFO exercised options to acquire additional common stock, potentially signaling confidence in the company's future.
- Correction of a previous administrative error enhances transparency and accuracy in reporting insider holdings.
Future Outlook
This Form 4 filing is a report of insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
Insider transaction reports (Form 4s) are routine disclosures for publicly traded companies, indicating changes in beneficial ownership by officers, directors, and significant shareholders. This specific filing reflects a standard option exercise by a key executive.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Correction | Correction of an administrative error in a previously filed Form 4 (March 27, 2023) regarding the omission of 5,000 option exercises, ensuring accurate disclosure of beneficial ownership. | 10/22/2025 | Improves transparency and accuracy of insider ownership reporting, aligning with SEC disclosure requirements. |
Stakeholder Impact
- Shareholders: May view the CFO's increased ownership positively as a sign of management's commitment and belief in the company's prospects.
- Regulatory Authorities: The correction of a past administrative error demonstrates adherence to SEC reporting standards.
Key Dates
| Date | Description |
|---|---|
| 02/17/2023 | Vesting date for one quarter of a 52,000 share stock option grant. |
| 03/27/2023 | Date of original Form 4 filing that contained an administrative error regarding 5,000 options. |
| 10/22/2025 | Transaction date for stock option exercises. |
| 10/23/2025 | Signature date of the reporting person's attorney-in-fact. |
| 07/30/2029 | Expiration date for 76,901 stock options exercised. |
| 02/16/2032 | Expiration date for 3,898 stock options exercised (part of a larger grant). |
Keywords
89bio, ETNB, Ryan Martins, CFO, Stock Option Exercise, Insider Transaction, Form 4, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.